Stock

The Best Five Sectors, #28

July 21, 2025
Investing

Strategic Acquisition of Aurumin Consolidates Sandstone

July 21, 2025
Investing

Resignation of Managing Director/CEO

July 21, 2025
Investing

US Slaps 93.5 Percent Tariff on Chinese Graphite

July 21, 2025
Investing

Shanghai Platinum Week Showcases China’s Dominance in Global PGMs Demand

July 21, 2025
Investing

Crypto Market Update: GENIUS Act Becomes First Federal Stablecoin Law in the US

July 21, 2025
Home Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

You may also like

Agreement to Acquire Major Drill-Ready Antimony-Gold-Tungsten Project in...

June 11, 2025

Oil and Gas Price Update: Q1 2025 in...

April 24, 2025

Crypto Market Recap: Bitcoin Breaks US$100,000 as ETF...

May 10, 2025

Crypto Market Recap: Trump Media Files for Third...

July 14, 2025

John Hancock to join White Cliff Minerals Board

June 24, 2025

3 Best-performing Canadian Cleantech Stocks of 2025

July 18, 2025

Resolution Minerals LtdTo Develop U.S. Government Engagement Strategy...

June 18, 2025

C29 Signs Binding HOA to Drive Growth

May 5, 2025

Investing in Uranium ETFs: 9 Options for Uranium...

May 10, 2025

Silver Crown Royalties Executes LOI with Kuya Silver...

June 19, 2025